We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

132 hedge funds and large institutions have $835M invested in MacroGenics in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,075% more call options, than puts

Call options by funds: $2.77M | Put options by funds: $236K

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

31% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 36

10% more capital invested

Capital invested by funds: $760M → $835M (+$75.2M)

6% more funds holding

Funds holding: 125 → 132 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
132
Holders Change
+7
Holders Change %
+5.6%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
47
Reduced
36
Closed
9
Calls
$2.77M
Puts
$236K
Net Calls
+$2.54M
Net Calls Change
+$1.81M

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$27.8M
2
HRCM
Hood River Capital Management
Florida
+$5.63M
3
AG
Artal Group
Luxembourg
+$4.46M
4
SIM
Spark Investment Management
New York
+$3.71M
5
Millennium Management
Millennium Management
New York
+$3.59M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$22.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$13.1M
3
BI
BVF Inc
California
-$5.4M
4
O
OrbiMed
New York
-$4.03M
5
JP Morgan Chase
JP Morgan Chase
New York
-$3.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
GH
76
GAM Holding
Switzerland
$676K -$1.64M -55,200 -71%
MLICM
77
Metropolitan Life Insurance Company (MetLife)
New York
$665K – – –
Manulife (Manufacturers Life Insurance)
78
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$661K +$5.06K +170 +0.8%
Stifel Financial
79
Stifel Financial
Missouri
$635K +$54.2K +1,821 +9%
EWM
80
Evercore Wealth Management
New York
$633K – – –
NFA
81
Nationwide Fund Advisors
Ohio
$621K – – –
GCP
82
GSA Capital Partners
United Kingdom
$620K +$304K +10,222 +97%
CAM
83
ClariVest Asset Management
California
$604K -$1.19M -40,141 -67%
Bank of America
84
Bank of America
North Carolina
$582K -$295K -9,920 -34%
AIG
85
American International Group
New York
$550K +$833 +28 +0.2%
DekaBank Deutsche Girozentrale
86
DekaBank Deutsche Girozentrale
Germany
$544K – – –
TAM
87
Tocqueville Asset Management
New York
$508K – – –
State Board of Administration of Florida Retirement System
88
State Board of Administration of Florida Retirement System
Florida
$481K +$3.27K +110 +0.7%
Tudor Investment Corp
89
Tudor Investment Corp
Connecticut
$465K +$79.8K +2,684 +21%
Citadel Advisors
90
Citadel Advisors
Florida
$409K -$412K -13,866 -50%
Wells Fargo
91
Wells Fargo
California
$390K +$115K +3,858 +42%
Morgan Stanley
92
Morgan Stanley
New York
$384K +$99K +3,328 +35%
MC
93
Muhlenkamp & Co
Pennsylvania
$364K -$109K -3,673 -23%
BG
94
BlackRock Group
United Kingdom
$349K +$83.8K +2,817 +32%
Citigroup
95
Citigroup
New York
$305K +$126K +4,252 +72%
VEA
96
Virtus ETF Advisers
New York
$292K – – –
DTL
97
Dynamic Technology Lab
Singapore
$287K +$285K +9,597 New
HI
98
HBK Investments
Texas
$281K +$280K +9,400 New
T. Rowe Price Associates
99
T. Rowe Price Associates
Maryland
$251K – – –
Barclays
100
Barclays
United Kingdom
$236K +$234K +7,860 +26,200%
2 3
4
5 6

MGNX Hedge Fund Activity: Q3 2016 in Review

132 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2016, worth a combined $835M — up 9.9% from $760M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MGNX positions and 9 closed out — a net gain of 8 holders — while 47 added to existing stakes and 36 trimmed.

The largest buyer was BB Biotech, adding an estimated $27.8M. The largest seller was Point72 Asset Management, cutting an estimated $22.1M.

  • 132 institutional investors held MacroGenics (MGNX) as of Q3 2016, up from 125 in Q2 2016.
  • Funds reported $835M of MacroGenics stock for Q3 2016, up 9.9% quarter-over-quarter.
  • 17 funds opened new MacroGenics positions in Q3 2016 and 9 closed out, a net change of +8 holders.
  • The largest MacroGenics buyer in Q3 2016 was BB Biotech, an estimated $27.8M added.
  • The largest MacroGenics seller in Q3 2016 was Point72 Asset Management, an estimated $22.1M sold.

Based on aggregated 13F filings for Q3 2016.